Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
JAMA Neurology|February 10, 2016
Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface AntibodiesThaís Armangué, Lidia Sabater, Estefanía Torres-Vega, et al.Annals of Hepatology|January 3, 2019
Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic EncephalopathyPlácido Espíritu-Ramírez, Nancy Y Ortega-Balderas, Laura Sevilla-Tapia, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 19, 2018
Progression of corticospinal tract dysfunction in pre-ataxic spinocerebellar ataxia type 2: A two-years follow-up TMS studyLuis Velázquez-Pérez, Roberto Rodríguez-Labrada, Reidenis Torres-Vega, et al.Microbes and Infection|July 5, 2022
Comparative virulence of the worldwide ST19 and emergent ST213 genotypes of Salmonella enterica serotype Typhimurium strains isolated from foodAdrián Gómez-Baltazar, Gerardo Vázquez-Marrufo, Humberto Astiazaran-Garcia, et al.Gene Therapy|October 24, 2014
Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemiaM A Torres-Vega, R Y Vargas-Jerónimo, A G Montiel-Martínez, et al.Journal of Neuroimmunology|August 1, 2013
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratomaMarina Frasquet, Luis Bataller, Estefanía Torres-Vega, et al.Physical Review. E|March 17, 2017
Quantum mechanical model for the anticarcinogenic effect of extremely-low-frequency electromagnetic fields on early chemical hepatocarcinogenesisJuan José Godina-Nava, Gabino Torres-Vega, Germán Octavio López-Riquelme, et al.Nutricion Hospitalaria|June 20, 2017
Metabolic syndrome and cardiovascular risk in diabetic population of El Hierro, Canary IslandsM Candelaria Martín-González, Ana María Torres-Vega, Emilio González-Reimers, et al.Cerebellum & Ataxias|March 16, 2019
Insights into cognitive decline in spinocerebellar Ataxia type 2: a P300 event-related brain potential studyRoberto Rodríguez-Labrada, Luis Velázquez-Pérez, Ricardo Ortega-Sánchez, et al.The Lancet. Neurology|April 8, 2014
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyLidia Sabater, Carles Gaig, Ellen Gelpi, et al.Pageof 6